Are old-old patients with major depression more likely to relapse than young-old patients during continuation treatment with escitalopram?

BMC Geriatrics

Volumn 11, Issue , 2011, Pages

  Lyketsos, Constantine G ^a   Weiller, Emmanuelle ^b   Katona, Cornelius ^c   Gorwood, Phillip ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b H LUNDBECK A S   (Denmark)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

AGE; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

AGE FACTORS; AGED; AGED, 80 AND OVER; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; RECURRENCE; SEROTONIN UPTAKE INHIBITORS;

EID: 78651369571     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/1471-2318-11-2     Document Type: Article

References (25)

1. Venlafaxine as a treatment for generalized anxiety disorders in older adults: pooled analysis of five randomized placebo-controlled clinical trials. IR Katz CF Reynolds GS Alexopoulos D Hackett (Pubitemid 34053018)
2. Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy. M Pinquart PR Duberstein JM Lyness, Am J Psychiatry 2006 163 1493 501 10.1176/appi.ajp.163.9.1493 16946172 (Pubitemid 44465748)
3. Fluoxetine Collaborative Group: a double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. GD Tollefson JC Bosomworth JH Heiligenstein JH Potvin S Holman, Int Psychogeriatrics 1995 7 89 104 10.1017/S1041610295001888
4. Escitalopram in the treatment of depressed elderly patients. S Kasper H de Swart HF Andersen, Am J Geriatr Psychiatry 2005 13 884 891 16223967 (Pubitemid 46638677)
5. Escitalopram in the acute treatment of depressed patients aged 60 years or older. A Bose D Li C Gandhi, Am J Geriatr Psychiatry 2008 16 14 20 10.1097/JGP.0b013e3181591c09 18165459
6. Old-Old Depression Study Group: Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. SP Roose HA Sackeim KR Krishnan, et al. Am J Psychiatry 2004 161 2050 2059 10.1176/appi.ajp.161.11.2050 15514406 (Pubitemid 39441406)
7. An eight-week, multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. LS Schneider JC Nelson CM Clary P Newhouse KR Krishnan T Shiovitz K Weihs Sertraline Elderly Depression Study Group, Am J Psychiatry 2003 160 1277 1285 10.1176/appi.ajp.160.7.1277 12832242 (Pubitemid 41070944)
8. Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence. JC Nelson K Delucchi LS Schneider, Am J Geriatr Psychiatry 2008 16 558 567 10.1097/01.JGP.0000308883.64832.ed 18591576
9. Escitalopram in the long-term treatment of major depressive disorder in elderly patients. S Kasper OM Lemming H de Swart, Neuropsychobiology 2006 54 152 159 10.1159/000098650 17230032
10. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial. S Mohamed K Osatuke M Aslam J Kasckow, Am J Geriatr Pharmacother 2006 4 201 209 10.1016/j.amjopharm.2006.08. 001 17062320 (Pubitemid 44575959)
11. New possibilities of treatment for panic attacks in elderly patients: escitalopram versus citalopram. L Rampello A Alvano R Raffaele M Malaguarnera I Vecchio, J Clin Psychopharmacol 2006 26 67 70 10.1097/01.jcp.0000195383.96383.25 16415709 (Pubitemid 43168391)
12. Escitalopram prevents relapse in older patients with major depressive disorder. P Gorwood E Weiller O Lemming C Katona, Am J Geriatr Psychiatry 2007 15 581 593 10.1097/01.JGP.0000240823.94522.4c 17586783
13. ICH. 1996 ICH Harmonised Tripartite Guideline E6, Guideline for Good Clinical Practice http://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/ Guidelines/Efficacy/E6-R1/Step4/E6-R1-Guideline.pdf
14. World Medical Association (WMA), Declaration of Helsinki: Ethical principles for medical research involving human subjects 2000 http://www.wma.net/en/30publications/10policies/b3/index.html
15. A new depression scale designed to be sensitive to change. SA Montgomery M sberg, Br J Psychiatry 1979 134 382 389 10.1192/bjp.134.4.382 444788 (Pubitemid 9136500)
16. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Y Lecrubier DV Sheehan E Weiller P Amorim KH Sheehan J Janavs GC Dunbar, Eur Psychiatry 1997 12 224 231 10.1016/S0924-9338(97)83296-8 (Pubitemid 27298915)
17. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, fourth edition text revision American Psychiatric Association, Washington, DC 2000 300.02
18. W Guy, ECDEU Assessment Manual for Psychopharmacology (rev., 1976) Biometric Laboratory The George Washington University, Kensington, Maryland. US Dept. of Health, Education, and Welfare - DHEW Publication No. (ADM) 1975 218 222
19. Use of SSRIs in "very old" depressed nursing home residents. B Trappler CI Cohen, Am J Geriatr Psychiatry 1998 6 83 89 9469218
20. Drug treatment of depression in frail elderly nursing home residents. JE Streim DW Oslin IR Katz BD Smith S DiFilippo TB Cooper T Ten Have, Am J Geriatr Psychiatry 2000 8 150 159 10804076 (Pubitemid 30226965)
21. A randomized, placebo-controlled trial of paroxetine in nursing home residents with non-major depression. AB Burrows C Salzman A Satlin K Noble BG Pollock T Gersh, Depress Anxiety 2002 15 102 110 10.1002/da.10014 12001178 (Pubitemid 34522470)
22. Course and rate of antidepressant response in the very old. AG Gildengers PR Houck BH Mulsant BG Pollock S Mazumdar MD Miller MA Dew E Frank DJ Kupfer CF Reynolds, J Affect Disord 2002 69 177 184 10.1016/S0165-0327(01)00334-2 12103464 (Pubitemid 34722883)
23. Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. JR Sneed BR Rutherford D Rindskopf, et al. Am J Geriatr Psychiatry 2008 16 65 73 10.1097/JGP.0b013e3181256b1d 17998306
24. Escitalopram therapy for major depression and anxiety disorders. DS Baldwin EH Reines C Guiton E Weiller, Ann Pharmacother 2007 41 1583 1592 10.1345/aph.1K089 17848424 (Pubitemid 47485624)
25. Maintenance treatment of major depression in old age. CF Reynolds MA Dew BG Pollock, et al. N Engl J Med 2006 354 1130 1138 10.1056/NEJMoa052619 16540613